Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Stock data | 2024 | Change |
---|---|---|
Price | $15.58 | N/A |
Market Cap | $899.91M | N/A |
Shares Outstanding | 57.76M | N/A |
Employees | 246.00 | N/A |